Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754468 · ClinicalTrials.gov registry record · Phase 4
Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.
A Phase 4 study of Esophageal Cancer and Barrett's Esophagus, sponsored by CSA Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT00754468: Completed Phase 4 study of Esophageal Cancer and Barrett's Esophagus, sponsored by CSA Medical.
NCT00754468 is a Phase 4 study of Esophageal Cancer and Barrett's Esophagus that has completed, run by CSA Medical. The registered enrollment target is 7 participants, below the 499-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00754468, a Phase 4 study of Esophageal Cancer and Barrett's Esophagus, has completed, sponsored by CSA Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the treatment effect, depth of injury, and side effects using technology involving the spray of liquid nitrogen through a catheter (CryoSpray AblationTM, "CSA" or "cryospray therapy") onto healthy tissue via esophagogastroduodenoscopy (EGD) using surgical resection specimens from subjects undergoing esophagectomy.
Primary Outcome
histopathological findings analyzed to determine max depth of injury (mm)
Conditions Studied
Interventions
- DEVICE Cryo Spray Ablation
Study Locations (1)
Florida
- University of Miami, Sylvester Comprehensive Cancer Center - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
What the finished NCT00754468 record still lists
NCT00754468 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 499-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cryo Spray Ablation is the first listed.
NCT00754468 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00754468 about?
NCT00754468 is a clinical study titled "Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.". The purpose of this study is to evaluate the treatment effect, depth of injury, and side effects using technology involving the spray of liquid nitrogen through a catheter (CryoSpray AblationTM, "CSA" or "cryospray therapy") onto healthy tissue via esophagogastroduodenoscopy (EGD) using surgical res...
What is the current status of trial NCT00754468?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2009-02. Estimated completion is 2012-03.
What conditions does trial NCT00754468 study?
This clinical trial studies the following conditions: Esophageal Cancer, Barrett's Esophagus.
What interventions are being tested in trial NCT00754468?
The interventions under investigation include: Cryo Spray Ablation (DEVICE).
Who is sponsoring clinical trial NCT00754468?
This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00754468 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00754468's enrollment target sits among peer trials
7 123rd of 123 higher than 1 of 123 other Esophageal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Esophageal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
RECRUITING · Phase 4
-
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
RECRUITING · Phase 4
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia